A pharmaceutical company executive defended his company’s recent 400% drug price increase, telling the Financial Times that his company had a „moral requirement to sell the product at the highest price.“
Papildomos nuorodos
Report: Pharma exec says he had ‘moral requirement’ to raise drug price 400%
Šis įrašas paskelbtas Sveikatos resursų skirstymo problemos kategorijose.
